Key result
CHF is linked to ~4x higher resting venous NPY levels that correlate with heart rate recovery.
Why the study?
Whether circulating neuropeptide Y levels increase during exercise in congestive heart failure when already elevated is controversial.
Do circulating neuropeptide Y (NPY) levels increase during exercise in CHF patients and correlate with performance indices?
Case-Control (n=31)
Do circulating neuropeptide Y (NPY) levels increase during exercise in CHF patients and correlate with performance indices?
Circulating NPY levels increase during exercise in CHF patients and correlate with heart rate recovery, suggesting NPY dynamics may provide insights into sympathetic responses and prognosis.
Answers are grounded in this paper and cite their sources.
Does not support NPY measurement in CHF care; hypothesis-generating for autonomic assessment during exercise.
High cardiac sympathetic drive and release of the sympathetic cotransmitter neuropeptide Y (NPY) are significant features of congestive heart failure (CHF), in which resting venous NPY levels are known to be associated with mortality. However, whether circulating NPY levels increase during exercise in CHF when they are already elevated is controversial. We sought to establish the dynamics of circulating NPY levels in CHF patients treated with contemporary medical therapy and devices in relationship to indices of performance linked to long-term prognosis. CHF patients (n = 15) underwent cardiopulmonary exercise testing with venous blood sampling at rest, peak exercise and recovery. These patients had significantly higher resting venous NPY levels compared with an age- and sex-matched control group of patients (n = 16) with normal left ventricular function (40 ± 6.9 vs. 9.0 ± 4.6 pg/mL, respectively; P < 0.0001). In CHF patients, NPY levels increased significantly from baseline to peak exercise (to 93.5 ± 42.1 pg/mL; P = 0.0004) and remained elevated during recovery (86.8 ± 44.6 pg/mL; P = 0.0018). The peak (r = 0.58, P = 0.0222) and recovery (r = 0.56, P = 0.0304) NPY levels and the ability to increase NPY from baseline (r = 0.53, P = 0.0427) showed significant positive correlations with heart rate recovery at 1 min, but not with peak oxygen consumption. In CHF patients, the ability to increase NPY levels on exertion is correlated with heart rate recovery, a known prognostic indicator for mortality. These findings suggest that NPY dynamics during exercise might provide valuable insights into sympathetic responses and prognosis in CHF patients.
No takes yet. Share an insight, caveat, or question.
Ayagama et al. (2025) conducted a case-control in Congestive heart failure (n=31). Cardiopulmonary exercise testing vs. Age- and sex-matched patients with normal left ventricular function was evaluated on Resting venous NPY levels (p=<0.0001). In CHF patients, resting venous NPY levels were higher than in controls and increased during exercise, correlating with heart rate recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: